Rylan Wells, NP
Nurse Practitioner · Mobile, ALNPI 1528788809
Payments from drug & device makers
Across 115 payments — averaging $28.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$761
- Sumitomo Pharma America, Inc.$369
- Myriad Genetic Laboratories, Inc.$266
- Merck$261
- Accord Healthcare, Inc.$223
- Endo Pharmaceuticals Inc.$201
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,07594%
- Education$1996%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 23 | $761 |
| Sumitomo Pharma America, Inc. | 18 | $369 |
| Myriad Genetic Laboratories, Inc. | 5 | $266 |
| Merck | 12 | $261 |
| Accord Healthcare, Inc. | 5 | $223 |
| Endo Pharmaceuticals Inc. | 9 | $201 |
| Astellas Pharma US Inc | 2 | $199 |
| Bayer | 7 | $184 |
| Endo USA, Inc. | 5 | $127 |
| Teleflex LLC | 2 | $105 |
| Procept Biorobotics Corporation | 2 | $88 |
| Urogen Pharma, Inc. | 4 | $84 |
| Dendreon Pharmaceuticals LLC | 3 | $77 |
| Novartis | 4 | $61 |
| Pfizer | 2 | $50 |
| Antares Pharma, Inc. | 2 | $31 |
| Tempus AI, Inc | 1 | $25 |
| 180 Medical, Inc. | 1 | $24 |
| Sun Pharmaceutical Industries Inc. | 1 | $20 |
| Boston Scientific | 1 | $19 |
| AstraZeneca | 1 | $18 |
| Verity Pharmaceuticals Inc. | 1 | $18 |
| Vertex | 1 | $17 |
| Mission Pharmacal Company | 1 | $16 |
| Tolmar, Inc. | 1 | $16 |
| Myovant Sciences Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,274 in reported general payments places this provider in the 85th percentile of 1,505 nurse practitioner providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 71 | $60,293 |
| MyrbetriqMirabegron | 93 | $57,714 |
| Methenamine Hippurate | 42 | $3,747 |
| Tamsulosin Hcl | 213 | $3,051 |
| Tolterodine Tartrate ErTolterodine Tartrate | 42 | $2,682 |
| Cefdinir | 66 | $1,055 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 78 | $1,030 |
| Finasteride | 52 | $788 |
| Estradiol | 12 | $746 |
| Testosterone Cypionate | 21 | $528 |
| Oxybutynin Chloride ErOxybutynin Chloride | 26 | $450 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 19 | $419 |
| Duloxetine Hcl | 12 | $386 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 20 | $370 |
| Oxybutynin Chloride | 14 | $301 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $369 | $60,29371 claims |
| Astellas Pharma US IncMyrbetriq | $199 | $57,71493 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,505 nurse practitioner providers in Alabama.
Other nurse practitioner in Mobile
- Ardie Pack MabienMobile$126K
- Wilma BaliemMobile$13K
- Erin RiscoMobile$11K
- Hope TindleMobile$9K
- Erin TannerAlabaster$141K
- Ginger McDanielBirmingham$27K
- Audrey MorganMontgomery$24K
- Hollie CrutchfieldDothan$22K
- Leah GravesBirmingham$21K
- Lauren DowneyBirmingham$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.